T1	Participants 513 574	26 patients with chronic angina pectoris receiving acebutolol
T2	Participants 223 319	21 patients with coronary artery disease who were receiving placebo, acebutolol, and propranolol
T3	Participants 981 1086	13 patients with stable angina pectoris, single-pass studies of left ventricular function with indium 113
